Dr. Saver is SA Vice-Chair and Professor of Neurology at UCLA, and Director of the UCLA Comprehensive Stroke and Vascular Neurology Program. Author of over 700 research articles, 3 books, and 40 book chapters, Dr. Saver's research interests are in acute stroke treatment, stroke prevention, neuroimaging, clinical trial design, and neurocognitive consequences of stroke. He served as PI of the NIH-NINDS FAST-MAG trial, Global Co-PI of the SWIFT PRIME trial, and Chair of the American Heart Association Stroke Council. He is currently Associate Editor at JAMA, the Journal of the American Medical Association, and Editorial Board Member at the journal Circulation, and is a recipient of both the Feinberg Award and the Distinguished Scientist Award from the American Heart Association/American Stroke Association.

Sean I. Savitz, MD is a tenured Professor of Neurology, holds the Frank M. Yatsu Chair in Neurology, and directs the Institute for Stroke and Cerebrovascular Disease at the University of Texas Health Science Center in Houston (UTHealth). He and his team run one of the largest academic stroke programs in the world, developing novel treatments and health care delivery models for patients with ischemic stroke and brain hemorrhage. Dr. Savitz oversees a bidirectional, translational laboratory and clinical research program on cell therapies in stroke and has been conducting some of the first clinical trials testing cell therapies in stroke patients. He also oversees a fellowship program to train stroke specialists and has won several teaching awards both in Boston and at UTHealth. He is an author of over 200 publications in the biomedical literature.

Jan F. Scheitz is consultant stroke neurologist and Professor of Clinical Stroke Research at the Department of Neurology Charité in Berlin, Germany and at the Center for Stroke Research Berlin (CSB). Dr. Scheitz is head of the research group •Integrative Cardio-Neurology•. Together with his group, his major research interests include all aspects of Heart & Brain interaction, post-stroke (cardiac) complications, mechanisms and prognostic impact of cardiac troponin elevation after stroke, and use of cardiovascular MRI in acute stroke. He is Fellow of the European Stroke Organisation (FESO) and founding member of the „Heart&Brain Task Force“ of the World Stroke Organisation (WSO). In 2016, he received the ESO Young Investigator Award for research about statin use and post-stroke hemorrhagic complications. Twitter handle: @JanFrisch

Dr. Peter Schellinger serves as Chairman in the Departments of Neurology and Neurogeriatry at Johannes Wesling Medical Center Minden, University Hospital of the Ruhr University Bochum in Minden, Germany. He is board certified for Neurology, Geriatrics and Intensive Care Medicine. After medical school in Aachen, Germany, he received his Training in Heidelberg with Werner Hacke, and continued research and work in Heidelberg as Assistant and Associate Professor of Neurology and attending interrupted for a year as Visiting Research Fellow at the NINDS, NIH, USA in Bethesda with Steven Warach. From 2006 to 2010 he worked as Professor and vice chairman at the Dept of Neurology, univ. at Erlangen with Stefan Schwab before moving to Minden in 2010. He has authored and coauthored over 300 publications with a current cumulative Impact Factor >1800 and a Hirsch Factor of 60. He served 8 years on the Board of Directors and 3 years on the Executive Committee of ESO.

An internationally recognized leader in telehealth and vascular neurology, Dr. Schwamm is best known for his 20-plus years of pioneering work in the research, development and dissemination of telemedicine-enabled stroke care (telestroke), as well as his leadership of the American Heart Association’s Get with the Guidelines® Stroke program, which monitors and improves stroke care at over 3000 US hospitals to date by analyzing over six million stroke admissions. He serves on the Board of Directors of the American Heart Association and is a member of many American Heart Association committees related to stroke prevention and Stroke Center Certification and has served as an expert consultant to the Massachusetts Department of Public Health, the Centers for Disease Control Paul Coverdell National Acute Stroke Registry, the Joint Commission and the International Consortium for Health Outcomes Measurement. Dr. Schwamm is the author of over 450 peer-reviewed articles, serves on the editorial board of Stroke and the International Advisory Board of The Lancet Digital Health, and has chaired many of the current practice guidelines for telehealth-enabled stroke care delivery. He is the recipient of numerous awards for innovation, leadership and stroke advocacy and has an active federally funded research portfolio. His research has been funded by NIH, PCORI, AHRQ, HRSA, CDC, and others.

Dr. Ivy Sebastian is a Consultant Neurologist, practicing at St. Stephen's Hospital, India. Her chief area of interest is stroke and post-stroke rehabilitation. As a young clinical researcher she envisions designing superior quality, low-cost or no cost stroke intervention studies specific to Low and Middle Income Countries. Her publications include those on Stroke management, thrombolysis, Stroke Systems of care, and task shifting in stroke rehabilitation. Towards the purpose of making stroke care better and uniformly accessible in low-resource countries, she has been involved with the WHO-South East Asian Region offices in the development of a designated stroke care institutional improvement program in multiple South-East Asian countries, and has also been instrumental in the drafting of stroke education manual targeting the primary health care level. Apart from research and clinical work, she is fond of travelling and music and enjoys dancing.

Sudhakar Selvaraj, MD, PhD, is an Associate professor and the Director of the Depression Research Program at the UTHealth Department of Psychiatry and Behavioral Sciences at Houston. He completed his psychiatry residency and doctorate at University of Oxford and fellowship training at the Maudsley Hospital and Institute of Psychiatry, London. He is interested in understanding the biology of mood disorders and biomarkers for personalizing treatments in mood disorders. He has substantial experience in psychopharmacology and brain PET and MRI imaging techniques. He is applying clinical neuroscience approaches to understand neuropsychiatric symptoms after stroke and epilepsy. He has won several awards, published >75 manuscripts and co-edited a book "Mood Disorders: Brain Imaging and Therapeutic Implications". His research is funded by NIMH, SAMHSA and UTHealth.

Dr. Seyman has graduated medical school with honors at Ben-Gurion University on 2007. She continued with an internship program followed by a residency in Neurology at the Tel-Aviv medical center. During her residency Dr. Seyman has developed an interest in advanced brain imaging in vascular and inflammatory brain pathologies. She has completed a research fellowship program at the University of Toronto performing advanced MRI analyses in neuroinflammatory brain diseases, with a special interest in high resolution T1 vessel wall imaging. Upon returning to Israel , Dr Seyman completed a second clinical fellowship program in Vascular Neurology , and is now acting as a staff neurologist and stroke attending in the stroke department of the Tel-Aviv medical center, and is the director of emergency neurology services with an emphasis on acute stroke care. Her main research interests are advanced and new imaging techniques in intracranial vasculopathies and small vessel disease, and their relation to post stroke cognitive decline.

Dr. Shah is the Consultant Physician and Strokologist at the Gold Coast University Hospital and Co-Chair of the Statewide Stroke Clinical Network, Clinical Excellence Queensland, Australia. His passion lies around hyperacute stroke management, quality assurance, and better patient outcomes. He is also Site PI for more than 10 major international stroke trials.

Director of the Institute of cerebrovascular pathology and stroke of the Federal center of brain research and neurotechnologies of the Federal Medical Biological Agency. Published more than 200 scientific works, including co-authored 6 books, more than 10 chapters in national guidance, educational, methodological and scientific manuals. Has publications in such leading journals as Lancet, The New England Journal of Medicine, Stroke, International Journal of Stroke, Journal of Stroke and Cerebrovascular Diseases. Since 2014 Executive Secretary of the National Stroke Association. Since 2016 chief freelance neurologist of the Moscow Healthcare Department. Since 2019, the member of the Scientific and Practical Council of the Ministry of Health of the Russian Federation.

Experienced Data Scientist with a demonstrated history of working in the information technology and services industry. Currently working as a Project Associate at Indian Institute of Technology Madras in Computational Neuroscience Lab. Skilled in Computational Neuroscience, Deep Learning, Machine Learning, Theatre, Java, Android Development, and Data Analysis. Strong engineering professional with a Bachelor of Technology focused in Computer Science from Northern India Engineering College.

Dr. Anjail Sharrief-Ibrahim is an Associate Professor of Neurology and the Director of Stroke Prevention for the Institute of Stroke and Cerebrovascular Disease. She runs the Stroke Clinic and the Stroke Transitions Education and Prevention (STEP) Clinical Program that she founded in 2014. Her research focuses on improving systems of care for post-stroke care and addressing inequities in stroke care and outcomes.